InsidersTradesSigma
申报总数
公司
▲ 买入（4 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
4
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Mohan Pankaj, 董事长兼首席执行官. Officer active across 1 company, notably Sonnet BioTherapeutics Holdings, Inc.. Aggregated, 8 disclosures have been published. Breakdown: 4 buys · 0 sell. Total volume traded: €114k. Activity tracked since 9 June 2021. The latest transaction was filed on 15 May 2023 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Mohan Pankaj
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报8 总计
7,554 股Common StockSEC:0001493152-24-048951:0
34,375 股Common StockSEC:0001493152-23-038573:0
标准退出：2024年1月25日 (T+90)
371,600 股@ US$0.22364.0% 占其流量Common StockSEC:0001493152-23-017528:0
标准退出：2023年8月13日 (T+90)
60,000 股@ US$0.58527.5% 占其流量Common StockSEC:0001493152-23-007915:0
标准退出：2023年6月13日 (T+90)
73,561 股Common StockSEC:0001493152-23-005473:0
74,205 股Common StockSEC:0001493152-22-036319:0
320,135 股Common StockSEC:0001493152-22-009482:0
4,000 股@ US$1.5454.5% 占其流量Common StockSEC:0001493152-21-013938:0
标准退出：2021年9月7日 (T+90)
8 条申报中的 8 条
About Mohan Pankaj
Pankaj Mohan is the Chairman, President, and CEO of Sonnet BioTherapeutics Holdings, Inc. In this role, he oversees the company's operations and guides its growth strategy. His experience in the biopharmaceutical sector is essential for the development of the company's products.
